3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
2
Carcinoma
2
Thyroid Neoplasms
1
Teratoma, Ovarian
1
Struma Ovarii
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
28
Nivolumab
13
Carboplatin
9
fludarabine
7
Paclitaxel
7
Gemcitabine
7
Docetaxel
7
Cyclophosphamide
7
Cisplatin
7
Trastuzumab
5
palbociclib
4
cemiplimab
4
avelumab
4
atezolizumab
4
Ipilimumab
4
Fluorouracil
4
Filgrastim
4
Drug Therapy
4
Cetuximab
4
fludarabine phosphate
3
epacadostat
3
durvalumab
3
Taxes
3
Oxaliplatin
3
Fulvestrant
3
zimberelimab
2
ulixertinib
2
trametinib
2
tisotumab vedotin
2
spartalizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
DNA
×
Head & Neck
×
Clear all
NCT04053114
2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn